Welcome to OM Pharma English - Espaņol - Português
Doxium® : Chronic venous insufficiency - Diabetic retinopathy
  Philosophy
  History
  Worldwide activity
  R & D
  Manufacturing
  Products
    Marketing Authorizations
    International Availability
  Main Products
    - Broncho-Vaxom
    - Dicynone
    - Doxium
    - Uro-Vaxom
    Other Products
    - Doxiproct
    - Doxiproct Plus
    - Sinomarin
  Health and Diseases
  News
  Contacts
  Careers and jobs
  FAQ


Products
homepage > products > doxium > particular remarks
   
  Doxium
 
Particular remarks

Incompatibilities
No incompatibility is known up to now.

Information
At therapeutic doses, calcium dobesilate may interfere with the assay of creatinine (too low values).
Information for
healthcare professionals
 
Properties/Effects
 
Composition
 
Pharmacokinetics
 
Indications
 
Dosage and administration
 
Limitations for use
 
Adverse effects
 
Interactions
 
Overdosage
 
Particular remarks
 
Presentation
 
Mechanism of action
Download
 
List of publications PDF file
Contact us Back home